Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Related Articles by Review for PubMed (Select 20801411)

1.

Pluripotent stem cell-derived natural killer cells for cancer therapy.

Knorr DA, Kaufman DS.

Transl Res. 2010 Sep;156(3):147-54. doi: 10.1016/j.trsl.2010.07.008. Epub 2010 Aug 1. Review.

2.

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

Kaufman DS.

Blood. 2009 Oct 22;114(17):3513-23. doi: 10.1182/blood-2009-03-191304. Epub 2009 Aug 3. Review.

3.

In vitro generation of immune cells from pluripotent stem cells.

Vandekerckhove B, Vanhee S, Van Coppernolle S, Snauwaert S, Velghe I, Taghon T, Leclercq G, Kerre T, Plum J.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1488-504. Review.

PMID:
21196243
4.

Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Luevano M, Madrigal A, Saudemont A.

Cell Mol Immunol. 2012 Jul;9(4):310-20. doi: 10.1038/cmi.2012.17. Epub 2012 Jun 18. Review.

5.

Concise review: human pluripotent stem cells in the treatment of spinal cord injury.

Lukovic D, Moreno Manzano V, Stojkovic M, Bhattacharya SS, Erceg S.

Stem Cells. 2012 Sep;30(9):1787-92. doi: 10.1002/stem.1159. Review.

6.

Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials.

Haeryfar SM.

Arch Iran Med. 2008 Mar;11(2):186-95. doi: 08112/AIM.0012. Review.

7.

Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies.

Kolb HJ, Simoes B, Schmid C.

Curr Opin Oncol. 2004 Mar;16(2):167-73. Review.

PMID:
15075911
8.

[Current situation and progression of induced pluripotent stem cells in treating spinal cord injury].

Liu W, Zhang SK, Yan M, Liu LD.

Zhongguo Gu Shang. 2011 Jul;24(7):616-20. Review. Chinese.

PMID:
21870412
9.

Rise of iPSCs as a cell source for adoptive immunotherapy.

Minagawa A, Kaneko S.

Hum Cell. 2014 Apr;27(2):47-50. doi: 10.1007/s13577-014-0089-8. Epub 2014 Feb 9. Review.

PMID:
24510519
10.

Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective.

Eguizabal C, Zenarruzabeitia O, Monge J, Santos S, Vesga MA, Maruri N, Arrieta A, Riñón M, Tamayo-Orbegozo E, Amo L, Larrucea S, Borrego F.

Front Immunol. 2014 Sep 15;5:439. doi: 10.3389/fimmu.2014.00439. eCollection 2014. Review.

11.

Clinical applications of natural killer T cell-based immunotherapy for cancer.

Motohashi S, Nakayama T.

Cancer Sci. 2008 Apr;99(4):638-45. doi: 10.1111/j.1349-7006.2008.00730.x. Epub 2008 Feb 21. Review.

PMID:
18294290
13.

The tumorigenicity of diploid and aneuploid human pluripotent stem cells.

Blum B, Benvenisty N.

Cell Cycle. 2009 Dec;8(23):3822-30. Epub 2009 Dec 14. Review.

14.
15.

Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.

Locatelli F, Bauquet A, Palumbo G, Moretta F, Bertaina A.

Immunol Lett. 2013 Sep-Oct;155(1-2):21-3. doi: 10.1016/j.imlet.2013.09.027. Epub 2013 Sep 30. Review.

PMID:
24091162
16.

Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Tang C, Drukker M.

Semin Immunopathol. 2011 Nov;33(6):563-72. doi: 10.1007/s00281-011-0269-5. Epub 2011 Apr 11. Review.

PMID:
21479877
17.

Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?

Salewski RP, Eftekharpour E, Fehlings MG.

J Cell Physiol. 2010 Mar;222(3):515-21. doi: 10.1002/jcp.21995. Review.

PMID:
20020443
18.

Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.

Kramer AS, Harvey AR, Plant GW, Hodgetts SI.

Cell Transplant. 2013;22(4):571-617. doi: 10.3727/096368912X655208. Epub 2012 Aug 27. Review.

PMID:
22944020
19.

Reprogrammed cells for disease modeling and regenerative medicine.

Cherry AB, Daley GQ.

Annu Rev Med. 2013;64:277-90. doi: 10.1146/annurev-med-050311-163324. Review.

20.

Cardiac applications for human pluripotent stem cells.

Shiba Y, Hauch KD, Laflamme MA.

Curr Pharm Des. 2009;15(24):2791-806. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk